Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8778347 | European Urology | 2018 | 8 Pages |
Abstract
Focal therapy of prostate cancer is the targeted destruction of cancer within a specific part of the prostate gland, sparing the rest of the prostate and nearby tissue. This procedure could potentially reduce side effects when compared with established standard treatments, such as surgery or radiotherapy, which treat the entire prostate. Studies show that for most men with low-risk cancer, active surveillance is the preferred treatment option. However, the available data regarding all forms of focal therapy are still poor and inconclusive. Consequently, due to both the lack of clear results associated with focal therapy and the difficulties in detecting all cancerous areas of the prostate, focal therapy should be considered an investigational modality only.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Henk G. van der Poel, Roderick C.N. van den Bergh, Erik Briers, Philip Cornford, Alex Govorov, Ann M. Henry, Thomas B. Lam, Malcolm D. Mason, Olivier Rouvière, Maria De Santis, Peter-Paul M. Willemse, Hendrik van Poppel, Nicolas Mottet,